Recruiting
Acute lymphocytic leukaemia recurrent+5
RecruitingA study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression
InvestigationalNo placebo
A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression
InvestigationalNo placebo
- Disease:Acute lymphocytic leukaemia recurrentAcute myeloid leukaemia refractory+4
- Substances:AZD3632
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:AZD3632
- Sponsor:AstraZeneca AB
